| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736475 | Autoimmunity Reviews | 2018 | 10 Pages |
Abstract
IE after treatment by rituximab can be extremely severe, especially in patients immunocompromised by several other drugs. Further studies should focus on the group with life-threatening polymicrobial infections.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jean-Jacques Tudesq, Guillaume Cartron, Sophie Rivière, David Morquin, Laura Iordache, Alfred Mahr, Valérie Pourcher, Kada Klouche, Diane Cerutti, Alain Le Quellec, Philippe Guilpain,